The US FDA has approved Moderna's new COVID-19 vaccine, mNEXSPIKE, amidst emerging coronavirus variants. It is approved for ...

Today, the World Health Organization (WHO) published its first-ever position paper on immunization products to protect ...

The WHO on Friday recommended all countries to use both maternal vaccine and a monoclonal antibody to protect babies against ...

Patients with RSV hospitalization have increased odds of any acute cardiovascular event compared with COVID-19 hospitalizations.

India's Ministry of Health has released new guidelines to help identify respiratory viral illness symptoms. Early recognition ...

The incidence of RSV across 5 respiratory virus seasons was substantial among adult patients with high-risk underlying conditions.

Adults with RSV-associated acute respiratory infection face a 2.7-fold higher risk for death within one year, according to a ...

A statewide immunization program for infants against respiratory syncytial virus (RSV), which began in 2024, has already ...

The new three-illness dashboard includes a history of outbreaks for any or all of the three respiratory illnesses. It ...

Respiratory syncytial virus (RSV) is the number one cause of hospitalization in infants, accounting for about 25% of all ...